Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00340808 · ClinicalTrials.gov registry record
Molecular Staging of Endometrial Cancer
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 5,492
- Enrollment target
NCT00340808: Completed study, sponsored by National Cancer Institute (NCI).
NCT00340808 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 5,492 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00340808 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 5,492 participants
- Enrollment target
Study Summary
This study, sponsored by NCI and the Gynecologic Oncology Group (GOG), will collect tissue samples from women with cancer of the endometrium (lining of the uterus). Researchers will use the samples to learn more about endometrial cancer and develop new treatments and methods of prevention. Women with endometrial cancer who are suitable candidates for surgery and who have not had prior retroperitoneal surgery or pelvic or abdominal radiation therapy may be eligible for this study. Candidates will be screened with a medical history and physical examination, blood tests, and endometrial biopsy (surgical removal of a small tissue sample) or dilation and curettage (D \& C). Participants will undergo hysterectomy (surgery to remove the uterus) along with removal of both fallopian tubes and ovaries. This is the standard surgical treatment for endometrial cancer. Lymph nodes in the pelvis near the main blood vessel in the abdomen are also removed to determine if the disease has spread to these nodes. If cancer is found involving other sites, the cancer in those areas may also be removed; examination of the tissues will determine if further therapy beyond surgery is needed. Before surgery, patients will complete a 20-minute questionnaire that includes questions about their background, reproductive history, menstruation and menopause, certain surgeries, birth control pills and hormone replacement therapy, other drugs and medicines, weight and height, smoking, medical history, and family history of cancer. Some of the tissue removed during surgery, plus a urine sample collected from a catheter bag during surgery, and blood drawn before surgery and at follow-up visits 6 weeks and 3 years after surgery, will be sent to the GOG Tissue Bank in Columbus, Ohio. This bank stores, processes, and distributes biological specimens from patients that agree to participate in studies conducted by the GOG. Patients will have follow-up visits 6 weeks after surgery, then every 6 months fo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,492 participants |
| Start Date | 2004-03-19 |
| Est. Completion | 2020-07-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00340808
The ClinicalTrials.gov registry entry for NCT00340808 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,492 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00340808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00340808 about?
NCT00340808 is a clinical study titled "Molecular Staging of Endometrial Cancer". This study, sponsored by NCI and the Gynecologic Oncology Group (GOG), will collect tissue samples from women with cancer of the endometrium (lining of the uterus). Researchers will use the samples to learn more about endometrial cancer and develop new treatments and methods of prevention. Women wi...
What is the current status of trial NCT00340808?
This trial is currently completed. The enrollment target is 5,492 participants. The study started on 2004-03-19. Estimated completion is 2020-07-16.
Who is sponsoring clinical trial NCT00340808?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.